PRGO
Perrigo Company plcNYSEHealthcare$10.85-1.36%ClosedMarket Cap: $1.49B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.34
EV/EBITDA
-5.91
DCF Value
$1,090.07
FCF Yield
10.0%
Div Yield
11.0%
Margins & Returns
Gross Margin
35.1%
Operating Margin
5.9%
Net Margin
-33.5%
ROE
-35.2%
ROA
-16.7%
ROIC
3.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.11B | 32.6% | $84.7M | $-1.42B | $-10.23 | $0.29 |
| FY 2025 | $4.25B | 35.1% | $343.3M | $-1.43B | $-10.29 | $1.16 |
| Q3 2025 | $1.04B | 36.1% | $72.6M | $7.5M | $0.05 | $0.29 |
| Q2 2025 | $1.06B | 34.4% | $45.4M | $-8.4M | $-0.06 | $0.29 |
| Q1 2025 | $1.04B | 37.6% | $46.9M | $-6.4M | $-0.05 | $0.29 |
| Q4 2024 | $1.14B | 33.9% | $114.2M | $-44.5M | $-0.32 | $0.28 |
| FY 2024 | $4.37B | 35.3% | $112.9M | $-171.8M | $-1.25 | $1.10 |
| Q3 2024 | $1.09B | 37.2% | $80.4M | $-21.0M | $-0.15 | $0.28 |
| Q2 2024 | $1.07B | 37.0% | $-26.5M | $-108.4M | $-0.77 | $0.28 |
| Q1 2024 | $1.08B | 33.1% | $-55.2M | $2.0M | $0.01 | $0.28 |
| Q4 2023 | $1.16B | 36.9% | $-15.6M | $-32.3M | $-0.24 | $0.27 |
| FY 2023 | $4.66B | 36.1% | $151.9M | $-12.7M | $-0.09 | $1.09 |